Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00005034 Information provided by Eastern Cooperative Oncology Group

First Received: April 6, 2000 Last Updated: June 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Falkson CI, Lawson DH, Ibrahim J, et al.: A randomised, placebo-controlled phase III trial of yeast derived GM-CSF vs. peptide vaccination vs. GM-CSF plus peptide vaccination vs. placebo in pts with 'no evidence of disease' after complete surgical resection of 'locally advanced' and / or stage IV melanoma. An Eastern Cooperative group trial . [Abstract] 4th International Conference on the Adjuvant Therapy of Malignant Melanoma, 15th-16th March 2002, London, UK A-I-03, 2002.